KCNN4 may weaken anti-tumor immune response via raising Tregs and diminishing resting mast cells in clear cell renal cell carcinoma

被引:16
作者
Cui, Yankang [1 ]
Shen, Tianyi [1 ]
Xu, Feng [1 ]
Zhang, Jing [2 ]
Wang, Yuhao [3 ]
Wu, Jiajin [3 ]
Bu, Hengtao [3 ]
Fu, Dian [1 ]
Fang, Bo [1 ]
Lv, Huichen [1 ]
Wang, Suchun [1 ]
Shi, Changjie [1 ]
Liu, Bianjiang [3 ]
He, Haowei [1 ]
Tang, Hao [1 ]
Ge, Jingping [1 ]
机构
[1] Nanjing Univ, Jinling Hosp, Clin Sch, Dept Urol,Med Coll, Nanjing, Peoples R China
[2] Southeast Univ, Sch Chem & Chem Engn, Jiangsu Prov Hitech Key Lab Biomed Res, Nanjing, Peoples R China
[3] Nanjing Med Univ, Dept Urol, Affiliated Hosp 1, Nanjing, Peoples R China
关键词
Renal cancer; ceRNA; Immune cells; KCNN4; Prognosis; CERNA; NETWORKS;
D O I
10.1186/s12935-022-02626-7
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Studies over the past decade have shown that competitive endogenous RNA (ceRNA) plays an essential role in the tumorigenesis and progression of clear cell renal cell carcinoma (ccRCC). Meanwhile, immune checkpoint blocker is gradually moving towards the first-line treatment of ccRCC. Hence, it's urgent to develop a new prediction model for the efficiency of immunotherapy. At present, there is no study to reveal the effect of ceRNA network on the efficiency of immunotherapy for ccRCC. Methods To systematically analyze the effect of ceRNA hub genes in ccRCCon immune response, we constructed prognosis models based on ceRNAs and immune cells, respectively. We constructed ceRNA network using hypergeometric distribution test and correlation analysis with R script based on The Cancer Genome Atlas (TCGA) database. We then applied the Cibersort algorithm to simulate the infiltration overview of immune cells in kidney renal clear carcinoma (KIRC) samples. Prognosis-related immune cells were screened and a predictive model of these cells was constructed. Prognosis-related immune cells and ceRNA hub genes were performed with co-expression analysis. Finally, qRT-PCR and immunofluorescence assays were performed to validate the results. Results The construction of ceRNA related prognosis model contained 8 hub genes, including RELT, MYO9B, KCNN4, SIX1, OTOGL, MALAT1, hsa-miR-130b-3p, and hsa-miR-21-5p. The area under the receiver operating characteristic curve (AUC) was 0.77 at 5 years. For the construction of immune cells prognosis model, 3 immune cells (T cells regulatory, Macrophages, Mast cells resting) were adopted, and the AUC was 0.65 at 5 years. We then merged the two models by correlation analysis and co-expression analysis. Finally, we found that KCNN4 positively correlates with T cells regulatory (Tregs) and negatively correlates with mast cells resting significantly. Furthermore, higher expression of KCNN4 may lead to a higher potential for immune evasion and lower efficiency for immune checkpoint inhibitors (ICIs). Conclusions Generally, this is the first study to assess the prognostic value of immune related ceRNA hub genes in ccRCC, and KCNN4 was finally demonstrated to be a key regulatory factor with strong correlation with Tregs and mast cells resting.
引用
收藏
页数:14
相关论文
共 28 条
  • [1] Infiltrating mast cells promote renal cell carcinoma angiogenesis by modulating PI3K → AKT → GSK3β → AM signaling
    Chen, Y.
    Li, C.
    Xie, H.
    Fan, Y.
    Yang, Z.
    Ma, J.
    He, D.
    Li, L.
    [J]. ONCOGENE, 2017, 36 (20) : 2879 - 2888
  • [2] VOLTAGE-DEPENDENT ION CHANNELS IN LYMPHOCYTES-T
    DECOURSEY, TE
    CHANDY, KG
    GUPTA, S
    CAHALAN, MD
    [J]. JOURNAL OF NEUROIMMUNOLOGY, 1985, 10 (01) : 71 - 95
  • [3] Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma
    Escudier, Bernard
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2019, 380 (12) : 1176 - 1178
  • [4] GABRP regulates chemokine signalling, macrophage recruitment and tumour progression in pancreatic cancer through tuning KCNN4-mediated Ca2+ signalling in a GABA-independent manner
    Jiang, Shu-Heng
    Zhu, Li-Li
    Zhang, Man
    Li, Rong-Kun
    Yang, Qin
    Yan, Jiang-Yu
    Zhang, Ce
    Yang, Jian-Yu
    Dong, Fang-Yuan
    Dai, Miao
    Hu, Li-Peng
    Li, Jun
    Li, Qing
    Wang, Ya-Hui
    Yang, Xiao-Mei
    Zhang, Yan-Li
    Nie, Hui-Zhen
    Zhu, Lei
    Zhang, Xue-Li
    Tian, Guang-Ang
    Zhang, Xiao-Xin
    Cao, Xiao-Yan
    Tao, Ling-Ye
    Huang, Shan
    Jiang, Yong-Sheng
    Hua, Rong
    Luo, Kathy Qian
    Gu, Jian-Ren
    Sun, Yong-Wei
    Hou, Shangwei
    Zhang, Zhi-Gang
    [J]. GUT, 2019, 68 (11) : 1994 - 2006
  • [5] Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
    Li, Bo
    Severson, Eric
    Pignon, Jean-Christophe
    Zhao, Haoquan
    Li, Taiwen
    Novak, Jesse
    Jiang, Peng
    Shen, Hui
    Aster, Jon C.
    Rodig, Scott
    Signoretti, Sabina
    Liu, Jun S.
    Liu, X. Shirley
    [J]. GENOME BIOLOGY, 2016, 17
  • [6] starBase v2.0: decoding miRNA-ceRNA, miRNA-ncRNA and protein-RNA interaction networks from large-scale CLIP-Seq data
    Li, Jun-Hao
    Liu, Shun
    Zhou, Hui
    Qu, Liang-Hu
    Yang, Jian-Hua
    [J]. NUCLEIC ACIDS RESEARCH, 2014, 42 (D1) : D92 - D97
  • [7] The ceRNA Network Has Potential Prognostic Value in Clear Cell Renal Cell Carcinoma: A Study Based on TCGA Database
    Liu, Haosheng
    Zhu, Zhaowen
    Fang, Jianxiong
    Liu, Tianqi
    Zhang, Zhenhui
    Zhao, Chao
    Pu, Xiaoyong
    Liu, Jiumin
    [J]. BIOMED RESEARCH INTERNATIONAL, 2020, 2020
  • [8] LINC00973 is involved in cancer immune suppression through positive regulation of Siglec-15 in clear-cell renal cell carcinoma
    Liu, Yanbin
    Li, Xingzhi
    Zhang, Changming
    Zhang, Hui
    Huang, Yali
    [J]. CANCER SCIENCE, 2020, 111 (10) : 3693 - 3704
  • [9] EAU Guidelines on Renal Cell Carcinoma: 2014 Update
    Ljungberg, Borje
    Bensalah, Karim
    Canfield, Steven
    Dabestani, Saeed
    Hofmann, Fabian
    Hora, Milan
    Kuczyk, Markus A.
    Lam, Thomas
    Marconi, Lorenzo
    Merseburger, Axel S.
    Mulders, Peter
    Powles, Thomas
    Staehler, Michael
    Volpe, Alessandro
    Bex, Axel
    [J]. EUROPEAN UROLOGY, 2015, 67 (05) : 913 - 924
  • [10] Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma
    Mantia, Charlene M.
    McDermott, David F.
    [J]. CANCER, 2019, 125 (23) : 4148 - 4157